JSPRW
Jasper Therapeutics, Inc.
Set alert
0.00 USD 0.00 -84.62%
0.0001 Day range 0.0039
0.0001 52-week range 0.0039
- YTD
- -98.94%
- 1 year
- -98.94%
- Open
- 0.08
- Prev close
- 0.0013
- Mkt cap
- 3.25K
- Vol
- 863.07K
- Avg vol
- 0
- EPS
- -3.84
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0001
- High
- 0.0039
- Forward P/E
- 0.00
- Beta
- 2.20
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Financial health
Altman Z-Score
-49.96 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.5×
FY 2019 5y median -1.3× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 8.5×
FY 2019 5y median 1.3× FY 2025
P/FCF -0.5×
FY 2019 5y median -1.6× FY 2025
EV/EBITDA -0.1×
FY 2019 5y median -0.1× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -220.0%
FY 2019 5y median -63.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -1826.1%
FY 2019 5y median -104.7% FY 2025
ROIC -338.1%
FY 2019 5y median -116.0% FY 2025
ROA -211.9%
FY 2019 5y median -77.9% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -5.6%
FY 2019 FY 2025
EPS (diluted) 19.2%
FY 2019 FY 2025
Free Cash Flow -22.2%
FY 2019 FY 2025
Financial Health
Current Ratio 2.6×
FY 2019 5y median 5.9× FY 2025
Quick Ratio 2.6×
FY 2019 5y median 5.9× FY 2025
Debt / Equity 0.3×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2019 5y median 1.0× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31